Eradication of Helicobacter pylori heals atrophic corpus gastritis caused by long-term treatment with omeprazole

Virchows Archiv

Volumn 434, Issue 1, 1999, Pages 91-94

  Stolte, Manfred ^a   Meining, Alexander ^d   Koop, Herbert ^b   Seifert, Erwin ^c  

^a INSTITUTE OF PATHOLOGY   (Germany)

^b HELIOS KLINIKUM BERLIN BUCH   (Germany)

^c KLINIKUM BRAUNSCHWEIG   (Germany)

^d NONE

Author keywords

Atrophy; Gastritis; Helicobacter pylori; Proton pump inhibitors

Indexed keywords

ANTIBIOTIC AGENT; GASTRIN; OMEPRAZOLE;

ACHLORHYDRIA; ADULT; ARTICLE; ATROPHY; BACTERICIDAL ACTIVITY; CASE REPORT; FOLLOW UP; GASTRITIS; GASTROESOPHAGEAL REFLUX; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; HYPERGASTRINEMIA; LYMPHOCYTIC INFILTRATION; MALE; PRIORITY JOURNAL;

ADULT; ANTI-ULCER AGENTS; GASTRITIS, ATROPHIC; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; OMEPRAZOLE;

EID: 0033003731     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004280050310     Document Type: Article

References (20)

1. 1. Crabtree JE, Wyatt JI, Trejdosiewicz LK, Peichl P, Nichols PH, Ramsay N, Primrose JN, Lindley IJD (1994) Interleukin-8 expression in Helicobacter pylori infected, normal, and neoplastic gastroduodenal mucosa. J Clin Pathol 47:61-66
2. 2. Dixon MF, Genta RM, Yardley JH, Correa P, International Workshop on the Histopathology of Gastritis (1996) Classification and grading of gastritis. The updated Sydney system. Am J Surg Pathol 20:1161-1181
3. 3. Faller G, Steininger H, Eck M, Hensen J, Hahn EG, Kirchner T (1996) Antigastric autoantibodies in Helicobacter pylori gastritis: prevalence, in-situ binding sites and clues for clinical relevance. Virchows Arch 427:483-486
4. 4. Faller G, Winter M, Steininger H, Lehn N, Meining A, Bayerdörffer E, Kirchner T (1997) Decrease of antigastric autoantibodies after cure of H. pylori infection. Gut 41 [Suppl 1]:A61
5. 5. Jönsson KÄ, Ström M, Bodemar G, Norrby K (1988) Histological changes in the gastroduodenal mucosa after long-term medical treatment with cimetidine or parietal cell vagotomy in patients with juxtapyloric ulcer disease. Scand J Gastroenterol 23:433-441
6. 6. Klinkenberg-Knol EC, Festen HPM, Jansen JBMJ, Lamers CBHW, Nelis F, Snel P, Lückers A, Dekkers CPM, Havu N, Meuwissen SGM (1994) Long-term treatment with omeprazole for refractory reflux oesophagitis: efficacy and safety. Ann Intern Med 121:161-167
7. 7. Kuipers EJ, Lundell L, Klinkenberg-Knol EC, Havu N, Festen HPM, Liedman B, Lamers CBHW, Dalenbäck J, Snel P, Nelis GF, Meuwissen SGM (1996) Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication. N Engl J Med 304:1018-1022
8. 8. Lamberts R, Creutzfeldt W, Strüber HG, Brunner G, Solcia E (1993) Long-term omeprazole therapy in peptic ulcer disease: gastrin, endocrine cell growth, and gastritis. Gastroenterology 104:1356-1370
9. 9. McLaren A (1994) Hp and pH revisited. Am J Gastroenerol 89: 1328 (A172)
10. 2-receptor antagonists and antacids have an aggravating effect on Helicobacter pylori gastritis in duodenal ulcer patients. Aliment Pharmacol Ther 11:729-734
11. 11. Negrini R, Savio A, Poiesi C, Appelmelk BJ, Buffoli F, Paterlini C, Cesari P, Graffeo M, Vaira D, Franzin G (1996) Antigenic mimicry between Helicobacter pylori and gastric mucosa in the pathogenesis of body atrophic gastritis. Gastroenterology 111:655-665
12. 12. Ricci V, Sommi P, Fiocca R, Cova E, Figura N, Romano M, Ivey KJ, Solcia E, Ventura U (1993) Cytotoxicity of Helicobacter pylori on human gastric epithelial cells in vitro: role of cytotoxin(s) and ammonia. Eur J Gastroenterol Hepatol 5:87-94
13. 13. Roland M, Berstad, A., Liavåg, I (1975) A histological study of gastric mucosa before and after proximal gastric vagotomy in duodenal ulcer patients. Scand J Gastroenterol 10:181-186
14. 14. Solcia E, Villani L, Fiocca R, Luinetti O, Boldorini R, Trespi E, Perego M, Alvisi C, Lazzaroni M, Bianchi Porro G (1994) Effect of eradication of Helicobacter pylori on gastritis in duodenal ulcer patients. Scand J Gastroenterol 29 [Suppl 201]:28-34
15. 15. Stolte M, Bethke B (1990) Elimination of Helicobacter pylori under treatment with omeprazole. Z Gastroenterol 28:271-274
16. 16. Stolte M, et al. (1992a) Omeprazole-induced pseudohypertrophy of gastric parietal cells. Z Gastroenterol 30:134-138
17. 17. Stolte M, Baumann H, Bethke B, Lauer E, Ritter M (1992b) Active autoimmune gastritis without total atrophy of the glands. Z Gastroenterol 30:729-733
18. 18. Stolte M, et al (1993) Giant fold gastritis - a special form of Helicobacter pylori associated gastritis. Z Gastroenterol 31:289-293
19. 19. Stolte M, Meining A, Schmitz JM, Alexandrinis T, Seifert E (1998) Changes in Helicobacter pylori-induced gastritis in the antrum and corpus under 12 months of treatment with omeprazole and lanzoprazole. Aliment Pharmacol Ther 12:247-253
20. 20. Wündisch T, Oberhuber G, Rappel S, Stolte M (1997) Helicobacter pylori-Eradikationstherapie bei Patienten mit atrophischer Korpusgastritis. Verh Dtsch Ges Pathol 81:763